SCHEMBL111202

SCHEMBL111202

O=C(O)c1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.54
AKR1C3 P42330 1/20 0.54
AKR1C2 P52895 1/20 0.54
AKR1C1 Q04828 1/20 0.54
TPMT P51580 1/20 0.52
TSHR P16473 4/20 0.50
CASP1 P29466 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
DPP4 P27487 1/20 0.46
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 2/20 0.46
HSD17B10 Q99714 2/20 0.46
RECQL P46063 1/20 0.46
GRIN1 Q05586 2/20 0.45
TP53 P04637 1/20 0.44
HCAR1 Q9BXC0 1/20 0.44
LMNA P02545 1/20 0.43
SPR P35270 1/20 0.42
TTR P02766 1/20 0.42
RXRA P19793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1301827 0.97 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL28392002 0.97 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
Hydrochloric Acid SCHEMBL2512939 0.97 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL5878784 0.97 AKR1C4 (0.52) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
Urea SCHEMBL29192961 0.93 AKR1C4 (0.48) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL8467899 0.85 AKR1C4 (0.63) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL29684531 0.85 AKR1C4 (0.63) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL5355330 0.85 SPR (0.55) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL348918 0.84 CYP3A4 (0.53) AKR1C4AKR1C3AKR1C2AKR1C1TPMT
SCHEMBL3765067 0.84 SMN1; SMN2 (0.52) AKR1C4AKR1C3AKR1C2AKR1C1TPMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 545 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN claimed
CN-117603604-B Preparation method of printing gloss oil with amino-terminated hyperbranched self-assembled polyamide as main component 江苏众立生包装科技有限公司 2024-05-24 CN claimed
CN-117603604-A Preparation method of printing gloss oil with amino-terminated hyperbranched self-assembled polyamide as main component 江苏众立生包装科技有限公司 2024-02-27 CN claimed
CN-117586116-A Preparation method of 2,4, 6-trichlorobenzoic acid 黑龙江立科新材料有限公司 2024-02-23 CN claimed
EP-4218413-A2 NON-AQUEOUS SOLUTION OF PLANT GROWTH REGULATORS AND SEMIPOLAR ORGANIC SOLVENT Stoller Enterprises, Inc. (US) 2023-08-02 EP claimed
US-20220073742-A1 FILLED THERMOPLASTIC COMPOSITIONS HAVING IMPROVED FLOW SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2022-03-10 US claimed
CN-112062998-A Method for manufacturing bamboo fiber wallboard capable of removing formaldehyde and releasing negative ions 佛山绿森林环保科技有限公司 2020-12-11 CN claimed
CN-111116617-A 2,4, 6-terbium trichlorobenzoate complex/calcium carbonate composite fluorescent material and preparation method thereof 阜阳师范学院 2020-05-08 CN claimed
EP-1456322-A1 GLYCERIN TRIESTER PLASTICIZER FERRO CORPORATION (US) 2004-09-15 EP claimed
EP-0852007-B1 BORATE STORAGE BUFFER AND SAMPLE DILUENT BECKMAN COULTER INC (US) 2004-07-14 EP claimed
US-20040006064-A1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents IVAX International GmbH (CH) 2004-01-08 US claimed
WO-2003054106-A1 GLYCERIN TRIESTER PLASTICIZER FERRO CORPORATION (US) 2003-07-03 WO claimed
US-20030116750-A1 Glycerin triester plasticizer POLYMER ADDITIVES, INC. 2003-06-26 US claimed
US-6579869-B1 Hydrolysis, esterification ONCOPHARM CORPORATION 2003-06-17 US claimed
EP-0672249-B1 USE OF CAPILLARY ELECTROPHORESIS FOR QUANTITATING THE CONCENTRATION OF PROTEIN COMPONENTS AND OF THE TOTAL PROTEIN IN FLUIDS BECKMAN COULTER INC (US) 1999-05-12 EP claimed
US-5490909-A Use of capillary electrophoresis for quantitating the concentration of protein components and of the total protein in fluids BECKMAN INSTRUMENTS, INC. (US) 1996-02-13 US claimed
EP-0672249-A1 USE OF CAPILLARY ELECTROPHORESIS FOR QUANTITATING THE CONCENTRATION OF PROTEIN COMPONENTS AND OF THE TOTAL PROTEIN IN FLUIDS BECKMAN INSTRUMENTS, INC. (US) 1995-09-20 EP claimed
WO-1995010041-A1 USE OF CAPILLARY ELECTROPHORESIS FOR QUANTITATING THE CONCENTRATION OF PROTEIN COMPONENTS AND OF THE TOTAL PROTEIN IN FLUIDS BECKMAN INSTRUMENTS, INC. (US) 1995-04-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006064-A1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents MCL1, CYCS, CYC1 AKR1C4 2459/4885AKR1C3 1142/4885AKR1C2 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.